Advertisement
Screener

Heartflow, Inc. (HTFL) Selling Expense

2.8 / 5 stars · 68/120 Roast Me

Heartflow, Inc. Selling Expense

Heartflow, Inc. (HTFL) reported Selling Expense of $75.71 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-18.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:SellingExpense · last filed 2026-03-18

  • Heartflow, Inc. selling expense for fiscal 2025 was $75.71M, a 13.18% increase from fiscal 2024.
  • Heartflow, Inc. selling expense for fiscal 2024 was $66.89M, a 25.33% increase from fiscal 2023.
  • Heartflow, Inc. selling expense for fiscal 2023 was $53.37M.
Period endSelling Expense 12 month
2025-12-31$75.71M
10-K · filed 2026-03-18
2024-12-31$66.89M
10-K · filed 2026-03-18
2023-12-31$53.37M
10-K · filed 2026-03-18

Similar stocks

Stock NameCountryMarket CapPE Ratio
ICU MEDICAL INC/DE (ICUI)United States$4.153B18.85
PULSE BIOSCIENCES, INC. (PLSE)United States$3.696B-24.47
iRhythm Holdings, Inc. (IRTC)United States$3.651B-281.06
HAEMONETICS CORP (HAE)United States$4.821B36.52
TELEFLEX INC (TFX)United States$5.093B-5.44
MERIT MEDICAL SYSTEMS INC (MMSI)United States$5.212B28.44
AtriCure, Inc. (ATRC)United States$3.089B
MiniMed Group, Inc. (MMED)United States$5.748B-16.85
UFP TECHNOLOGIES INC (UFPT)United States$2.308B28.37
Inspire Medical Systems, Inc. (INSP)United States$1.990B9.55